What Researchers Did
The researchers investigated patients' perspectives on hyperbaric oxygen treatment for osteoradionecrosis, a known complication of head and neck cancer radiation therapy.
What They Found
Osteoradionecrosis (ORN) affects 5-7% of patients receiving radiation therapy for head and neck cancer. Hyperbaric oxygen treatment (HBOT) involves breathing 100% oxygen under pressure for 90 minutes daily, five days a week, for six weeks. In Denmark, HBOT is offered at two facilities with distinct organizational structures.
What This Means for Canadian Patients
Canadian patients with osteoradionecrosis, a complication of radiation therapy for head and neck cancer, may consider hyperbaric oxygen treatment as a therapeutic option. This treatment involves daily sessions of breathing 100% oxygen under pressure over several weeks.
Canadian Relevance
This study has no direct Canadian connection as it focuses on hyperbaric oxygen treatment availability and patient perspectives within Denmark.
Study Limitations
A significant limitation is that the abstract provides only background information on osteoradionecrosis and hyperbaric oxygen treatment, without detailing the study's methodology or specific findings.